查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2003942

體外受精（IVF）設備及耗材市場：2026-2032年全球市場預測（依產品類型、技術、自動化程度及最終用戶分類）

IVF Devices & Consumables Market by Product Type, Technique, Automation Level, End Users - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年體外受精（IVF）設備和耗材市場價值為39.7億美元，預計2026年將成長至44.8億美元，複合年成長率為13.88%，到2032年將達到98.7億美元。

主要市場統計數據
基準年 2025 39.7億美元
預計年份：2026年 44.8億美元
預測年份 2032 98.7億美元
複合年成長率 (%) 13.88%

清晰而現代的介紹，闡述了技術、臨床和操作因素如何改變輔助生殖技術中設備和耗材的使用。

輔助生殖技術生態系統正經歷一段快速創新和營運轉型期，其驅動力包括技術進步、病患群體結構變化以及臨床通訊協定的持續演進。隨著生殖醫學日益專業化，體外受精流程中的關鍵醫療設備和耗材正面臨著來自臨床醫生、醫院管理者和檢查室管理人員的更嚴格審查，他們要求這些產品具備更高的可靠性、更優異的性能以及在整個診療過程中無縫銜接的能力。

對正在重塑整體生殖醫學領域的產品設計、檢查室工作流程和籌資策略的關鍵技術和臨床變革進行分析總結。

輔助生殖技術整體正在經歷一場重大變革，重塑著臨床實踐和商業性格局，創新正朝著自動化、數位化和以患者為中心的照護模式發展。延時成像和微流體系統的進步使胚胎學家能夠在發育週期的早期做出更明智、更可重複的決策，從而減少檢查室間的差異，並提高胚胎選擇的實證標準。

對 2025 年美國實施的關稅措施對生殖醫學領域的供應鏈、採購決策和籌資策略的累積影響進行詳細檢驗。

美國2025年實施的新關稅迫使整個輔助生殖技術產業重新評估供應鏈策略和採購慣例，迫使製造商和終端用戶重新審視其採購、定價和庫存管理政策。依賴跨境製造和進口零件的供應商正面臨日益成長的成本壓力，這加速了關於近岸外包、雙重採購和本地組裝的討論，以保護關鍵供應鏈免受關稅波動的影響。

綜合細分分析，解釋產品類型、最尖端科技、臨床應用和最終用戶優先級如何共同決定採用和購買行為。

對產品、技術、應用和使用者群體的詳細分析揭示了體外受精（IVF）設備和耗材整個生態系統中不同的需求促進因素和採用模式。就產品類型而言，耗材類別（包括配件、培養基、一次性產品和檢測套組）往往反映了重複的臨床消費模式，並且對無菌性和批間一致性有著更嚴格的監管。同時，設備領域（涵蓋冷凍保存系統、胚胎監測系統、培養箱、雷射系統和顯微操作系統）通常需要更長的資本週期，並且需要與實驗室資訊系統進行更高級的整合。

詳細的區域分析表明，不同的法規結構、報銷趨勢和醫療保健基礎設施如何塑造世界各地的需求和供應商策略。

區域趨勢塑造了輔助生殖技術的策略重點和投資模式，獨特的法規環境、報銷框架和醫療基礎設施影響醫療設備和耗材的研發和採購。在美洲，需求主要由私人生育服務機構和大規模綜合醫療系統共同驅動，這些機構注重批量採購、品質保證和臨床結果基準評估，這為兼具臨床證據和可擴展服務能力的供應商創造了有利條件。

對競爭行為進行策略評估，重點介紹成熟公司、創新公司和合作夥伴關係如何塑造產品系列、商業化和客戶維繫。

體外受精（IVF）設備及耗材市場的競爭格局由成熟的醫療設備製造商、專業的診斷試劑供應商以及數量不斷成長的專業技術Start-Ups共同構成。成熟企業通常利用其廣泛的業務基礎、服務網路和良好的合規記錄來贏得醫院和診所的青睞，而新參與企業則往往透過顛覆性技術、平台整合以及靈活的打入市場策略來展開競爭，這些策略強調循證實踐和與臨床醫生的合作。

為增強生殖技術的韌性、加速推廣應用和最佳化長期商業性成果，提出切實可行的、優先考慮的營運、商業、研發建議。

產業領導企業應推動採取協調一致的方法，將創新、供應鏈韌性和臨床證據的累積相結合，以保持競爭力並加速技術應用。應優先投資於能夠帶來明確臨床價值的技術，例如先進的成像技術和自動化冷凍保存解決方案，同時加強品管體系，以滿足不同地區的監管要求。這種兼顧性能驗證和合規性的雙管齊下策略將減少採購評估中的阻力，並加速臨床應用。

本研究透明地展示了一種混合方法調查方法，結合了對醫療保健專業人員的訪談、技術文獻回顧和檢驗驗證，以檢驗有關醫療設備和耗材的見解。

本研究途徑結合了對臨床和商業相關人員的結構化訪談以及對技術、監管和同行評審文獻的全面回顧，確保了研究結果的可靠性和多方驗證。主要研究包括對實驗室經理、胚胎學家、採購經理和設備工程師的深入訪談，以獲取關於設備性能、耗材可靠性、服務預期和推廣應用障礙的第一手觀點。這些訪談旨在揭示公開資訊來源中未明確提及的實際操作情況，例如維護週期、培訓需求以及實際應用中的挑戰。

這個簡潔的結論清楚地表明，創新、驗證和供應鏈韌性如何結合決定競爭優勢和臨床部署的軌跡。

對現有證據的全面分析表明，體外受精（IVF）設備及耗材行業正處於技術創新、監管和供應鏈務實三者交匯的十字路口，這決定了其短期戰略重點。臨床醫生對能夠提高可重複性並降低檢查室間差異的技術需求旺盛，而能夠將檢驗的性能與完善的服務模式相結合的供應商則更有可能進入許可權優先採購管道。鑑於近期貿易政策的變化和物流壓力，供應鏈韌性和靈活的生產能力已成為策略性要求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 體外受精（IVF）設備及耗材市場：依產品類型分類

  • 消耗品
    • 配件
    • 冷凍保存耗材
    • 培養基
    • 一次性產品和塑膠製品
    • 精子分選培養基和設備
    • 檢測套組
  • 裝置
    • 冷凍保存系統
    • 影像和監測系統
    • 培養箱
    • 雷射系統
    • 微型機械手臂系統
    • 卵子吸取系統
    • 精子分析和製備系統
    • 工作站及通風罩

第9章 體外受精（IVF）設備及耗材市場：依技術分類

  • 輔助孵化
  • 常規體外受精
  • 冷凍保存
    • 胚胎冷凍保存
    • 卵子冷凍保存
    • 精子冷凍保存
  • 生育力保存
  • ICSI
  • IUI
  • PGT
    • PGT-A
    • PGT-M
    • PGT-SR

第10章 體外受精（IVF）設備及耗材市場：依自動化程度分類

  • 全自動
  • 手動的
  • 半自動

第11章 體外受精（IVF）設備及耗材市場：依最終用戶分類

  • 合約研究與外包體外受精實驗室
  • 冷凍保存庫和精子庫
  • 診斷和基因檢測實驗室
  • 醫院
  • 體外受精（IVF）診所
  • 研究和學術機構
  • 研究中心

第12章 體外受精（IVF）設備及耗材市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 體外受精（IVF）設備及耗材市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 體外受精（IVF）設備及耗材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 美國體外受精（IVF）設備與耗材市場

第16章 中國體外受精（IVF）設備及耗材市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BioIVT, LLC
  • BioLife Solutions, Inc.
  • Carl Zeiss AG
  • CIVCO Medical Solutions
  • Cook Group Incorporated
  • CooperSurgical Inc
  • Corning Incorporated
  • Cryoport, Inc.
  • Eppendorf AG
  • Esco Lifesciences Group
  • Fertipro NV
  • FUJIFILM Corporation
  • Genea Biomedx Pty Ltd
  • Godrej Astec
  • Hamilton Thorne Inc.
  • Hunter Scientific Ltd.
  • IMV Technologies
  • IVF Express
  • IVFsynergy Ltd
  • Kitazato Corporation
  • Labotect GmbH
  • Memmert GmbH+Co. KG
  • Merck KGaA
  • Nidacon International AB
  • Nikon Corporation
  • Nipro Corporation
  • Olympus Corporation
  • Overture Life, Inc.
  • Rocket Medical plc
  • Sysmex Corporation
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • TMRW Life Sciences, Inc.
  • Trajan Scientific Australia Pty Ltd.
  • Vitrolife Group
Product Code: MRR-885131BE19AC

The IVF Devices & Consumables Market was valued at USD 3.97 billion in 2025 and is projected to grow to USD 4.48 billion in 2026, with a CAGR of 13.88%, reaching USD 9.87 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.97 billion
Estimated Year [2026] USD 4.48 billion
Forecast Year [2032] USD 9.87 billion
CAGR (%) 13.88%

A clear and contemporary introduction describing how technological, clinical, and operational drivers are reshaping device and consumable practices across assisted reproduction

The assisted reproductive technology ecosystem is experiencing a period of intense innovation and operational transformation driven by technological advances, shifting patient demographics, and evolving clinical protocols. As reproductive medicine becomes increasingly specialized, devices and consumables integral to in vitro fertilization workflows are gaining heightened scrutiny from clinicians, hospital administrators, and laboratory directors who demand higher reliability, better performance, and streamlined integration across the care pathway.

Clinics are adopting laboratory automation, enhanced imaging, and refined cryopreservation techniques to improve procedural consistency and patient outcomes, while diagnostic laboratories and research centers are expanding their use of sensitive assays and next-generation analysis tools. These parallel trends have created a landscape where device interoperability, regulatory compliance, and supply chain resilience are as critical as device performance itself. Consequently, stakeholders are prioritizing partnerships that combine technical excellence with strong service models, and they are increasingly favoring suppliers who can demonstrate robust quality systems, transparent validation data, and scalable manufacturing capabilities.

An analytical synthesis of the pivotal technological and clinical transformations reshaping product design, laboratory workflows, and procurement strategies across reproductive healthcare

Major transformative shifts are redefining clinical practice and commercial dynamics across assisted reproductive technologies, with innovation converging on automation, digitalization, and patient-centric care models. Advances in time-lapse imaging and microfluidic systems are enabling embryologists to make more informed, reproducible decisions earlier in the development cycle, reducing variability between laboratories and elevating standards of evidence for embryo selection.

Parallel developments in cryopreservation techniques, including refined vitrification protocols and automated cryostorage systems, are lowering procedural risk and extending the logistical reach of fertility services. At the same time, the rise of 3D culture systems and dry thawing innovations is altering laboratory workflows, prompting equipment suppliers to rethink form factor, ease of use, and integration with existing incubator and monitoring infrastructures. These technology shifts are accompanied by growing emphasis on regulatory rigor and clinical validation, which in turn influences procurement cycles and long-term capital planning for healthcare institutions and specialized clinics.

A nuanced examination of the cumulative effects of United States tariff measures implemented in 2025 on supply chains, sourcing decisions, and procurement strategies within reproductive health sectors

The introduction of new United States tariffs in 2025 has created a recalibration of supply chain strategies and procurement practices across the assisted reproduction sector, prompting manufacturers and end users to reassess sourcing, pricing, and inventory policies. Suppliers that rely on cross-border manufacturing and imported components have faced increased cost pressure, which has accelerated conversations about nearshoring, dual-sourcing, and localized assembly to shield critical supply lines from tariff volatility.

Clinics and diagnostic laboratories have adapted by tightening inventory management and by favoring vendors who can demonstrate transparent landed-cost models and shorter lead times. In parallel, distributors and equipment service providers have been compelled to renegotiate contracts and to offer bundled services that mitigate the operational impact of higher import-related expenses. For innovators and smaller suppliers, the tariff environment has highlighted the strategic value of manufacturing flexibility and regulatory readiness, incentivizing investment in compliance documentation and in partnerships that reduce exposure to trade policy changes.

An integrated segmentation analysis that explains how product types, cutting-edge technologies, clinical applications, and end-user priorities jointly determine adoption and purchasing behavior

A granular view of product, technology, application, and user segments reveals differentiated demand drivers and adoption patterns across the IVF device and consumable ecosystem. When considering product type, the consumables category-including accessories, culture media, disposables, and test kits-tends to reflect recurring clinical consumption patterns and tighter regulatory scrutiny around sterility and batch consistency, whereas the instruments side-encompassing cryopreservation systems, embryo monitoring systems, incubators, laser systems, and micromanipulator systems-often commands longer capital cycles and higher integration requirements with laboratory information systems.

From a technology perspective, innovations such as 3D culture systems, dry thawing technology, microfluidics, and time-lapse imaging are shaping both laboratory workflows and clinical protocols by enabling more automated, reproducible, and data-rich approaches to embryology. In terms of application, segments like cryopreservation, in vitro fertilization procedures more broadly, and intracytoplasmic sperm injection each carry distinct device and consumable profiles, with cryopreservation prioritizing storage reliability and thermal control while ICSI emphasizes precision micromanipulation and ultra-clean disposables. Finally, end-user segmentation across diagnostics laboratories, hospitals, IVF clinics, and research centers highlights divergent procurement behaviors: diagnostics laboratories and research centers often emphasize analytical precision and flexibility for experimental workflows, hospitals prioritize regulatory alignment and scalability for integrated patient services, and dedicated IVF clinics focus on throughput optimization, patient experience, and outcome consistency.

A detailed regional insight narrative showing how distinct regulatory frameworks, reimbursement dynamics, and healthcare infrastructures shape demand and supplier strategies across global territories

Regional dynamics are shaping strategic priorities and investment patterns in assisted reproductive technologies, with distinctive regulatory environments, reimbursement frameworks, and healthcare infrastructure influencing how devices and consumables are developed and procured. In the Americas, demand is driven by a mix of private fertility providers and large integrated health systems that emphasize consolidated purchasing, quality assurance, and clinical outcome benchmarking, creating fertile ground for suppliers that combine clinical evidence with scalable service capabilities.

Across Europe, the Middle East & Africa, varied regulatory regimes and heterogeneous reimbursement policies make market entry and expansion more complex, favoring suppliers who can offer adaptable validation packages and local regulatory expertise. Investment in laboratory modernization and fertility access initiatives is uneven but growing, which places a premium on flexible commercial models and strong distributor relationships. In the Asia-Pacific region, rapid clinic expansion, increasing demand linked to demographic shifts, and heightened adoption of advanced technologies are fostering competitive dynamics where cost efficiency, local manufacturing partnerships, and rapid post-market support are decisive factors for long-term success.

A strategic assessment of competitive behaviors highlighting how incumbents, innovators, and collaborative partnerships are shaping product portfolios, commercialization, and customer retention

Competitive dynamics across the IVF devices and consumables landscape are being driven by a mix of established clinical device manufacturers, specialized diagnostics suppliers, and a growing cohort of focused technology startups. Incumbent companies typically leverage broad commercial footprints, service networks, and regulatory track records to secure hospital and clinic accounts, while newer entrants often compete through disruptive technologies, platform integrations, and agile go-to-market strategies that emphasize evidence generation and clinician collaboration.

Strategic partnerships, co-development agreements, and selective acquisitions have become common mechanisms for filling capability gaps, accelerating time to clinic, and expanding portfolios into complementary product lines. Sales and support models are evolving to include outcome-based contracting and extended service agreements that align supplier incentives with clinical performance metrics. Meanwhile, suppliers that invest in robust quality systems, rigorous clinical validation, and responsive technical service demonstrate tangible advantages in tender processes and long-term customer retention, particularly when paired with digital tools for monitoring device performance and consumable traceability.

A pragmatic and prioritized set of operational, commercial, and R&D recommendations to strengthen resilience, drive adoption, and optimize long-term commercial outcomes in reproductive technology

Industry leaders should pursue a coordinated set of actions that align innovation, supply chain resilience, and clinical evidence generation to sustain competitiveness and drive adoption. Prioritize investments in technologies that offer clear clinical value, such as enhanced imaging and automated cryostorage solutions, while concurrently strengthening quality management systems to meet the varied regulatory expectations across regions. This dual focus on validated performance and compliance will reduce friction during procurement evaluations and accelerate clinical acceptance.

At the same time, diversify sourcing strategies to mitigate exposure to trade policy shifts and logistical disruptions by developing nearshore assembly options or multi-supplier component sourcing. Engage clinicians and laboratory professionals early in product development to co-create workflows that integrate seamlessly with existing systems, and structure commercial propositions around service, training, and outcome support rather than simple product delivery. Finally, build modular pricing and contract options that accommodate differing capital constraints among hospitals, diagnostic centers, and independent clinics, thereby widening addressable opportunities without undermining margin integrity.

A transparent exposition of a mixed-methods research methodology combining practitioner interviews, technical literature review, and triangulation to validate device and consumable insights

The research approach combined structured primary engagement with clinical and commercial stakeholders and a comprehensive review of technical, regulatory, and peer-reviewed literature to ensure robust, triangulated insights. Primary engagements included in-depth interviews with laboratory directors, embryologists, procurement managers, and device engineers to capture firsthand perspectives on device performance, consumable reliability, service expectations, and adoption barriers. These interviews were designed to surface operational realities that are not always explicit in published sources, including maintenance cycles, training needs, and real-world integration challenges.

Secondary research encompassed peer-reviewed scientific studies, regulatory guidance documents, clinical society recommendations, and product instruction materials to validate technical claims and to contextualize emerging technologies. Findings were synthesized through thematic analysis and cross-checked against practitioner feedback to ensure consistency and practical relevance. Where possible, validation exercises compared reported device features and workflows across multiple independent sources, and methodological limitations were documented to inform users about the scope and applicability of the insights provided.

A concise conclusion articulating how innovation, validation, and supply chain resilience collectively determine competitive advantage and clinical adoption trajectories

Synthesis of the evidence indicates that the IVF devices and consumables domain is at an inflection point where technical innovation, regulatory scrutiny, and supply chain pragmatism intersect to define near-term strategic priorities. Technologies that improve reproducibility and reduce laboratory variability are being prioritized by clinicians, and suppliers who can pair validated performance with comprehensive service models stand to gain preferential access to procurement channels. Supply chain resilience and flexible manufacturing emerge as strategic imperatives in light of recent trade policy shifts and logistics pressures.

In sum, success in this sector will favor organizations that integrate rigorous clinical validation, adaptable commercial models, and operational agility. Stakeholders who invest in clinician partnerships, transparent quality systems, and multi-regional support capabilities will be better positioned to meet the evolving expectations of laboratories, hospitals, and dedicated fertility clinics, while maintaining the ability to respond to policy and regulatory changes as they arise.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. IVF Devices & Consumables Market, by Product Type

  • 8.1. Consumables
    • 8.1.1. Accessories
    • 8.1.2. Cryopreservation Consumables
    • 8.1.3. Culture Media
    • 8.1.4. Disposables & Plasticware
    • 8.1.5. Sperm Selection Media & Devices
    • 8.1.6. Test Kits
  • 8.2. Instruments
    • 8.2.1. Cryopreservation Systems
    • 8.2.2. Imaging & Monitoring Systems
    • 8.2.3. Incubators
    • 8.2.4. Laser Systems
    • 8.2.5. Micromanipulator Systems
    • 8.2.6. Ovum Aspiration Systems
    • 8.2.7. Sperm Analysis & Preparation Systems
    • 8.2.8. Workstations & Hoods

9. IVF Devices & Consumables Market, by Technique

  • 9.1. Assisted Hatching
  • 9.2. Conventional IVF
  • 9.3. Cryopreservation
    • 9.3.1. Embryo Cryopreservation
    • 9.3.2. Oocyte Cryopreservation
    • 9.3.3. Sperm Cryopreservation
  • 9.4. Fertility Preservation
  • 9.5. ICSI
  • 9.6. IUI
  • 9.7. PGT
    • 9.7.1. PGT-A
    • 9.7.2. PGT-M
    • 9.7.3. PGT-SR

10. IVF Devices & Consumables Market, by Automation Level

  • 10.1. Fully Automated
  • 10.2. Manual
  • 10.3. Semi-Automated

11. IVF Devices & Consumables Market, by End Users

  • 11.1. Contract Research & Outsourced IVF Labs
  • 11.2. Cryobanks & Sperm Banks
  • 11.3. Diagnostic & Genetic Laboratories
  • 11.4. Hospitals
  • 11.5. IVF Clinics
  • 11.6. Research & Academic Institutes
  • 11.7. Research Centers

12. IVF Devices & Consumables Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. IVF Devices & Consumables Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. IVF Devices & Consumables Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States IVF Devices & Consumables Market

16. China IVF Devices & Consumables Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. BioIVT, LLC
  • 17.6. BioLife Solutions, Inc.
  • 17.7. Carl Zeiss AG
  • 17.8. CIVCO Medical Solutions
  • 17.9. Cook Group Incorporated
  • 17.10. CooperSurgical Inc
  • 17.11. Corning Incorporated
  • 17.12. Cryoport, Inc.
  • 17.13. Eppendorf AG
  • 17.14. Esco Lifesciences Group
  • 17.15. Fertipro NV
  • 17.16. FUJIFILM Corporation
  • 17.17. Genea Biomedx Pty Ltd
  • 17.18. Godrej Astec
  • 17.19. Hamilton Thorne Inc.
  • 17.20. Hunter Scientific Ltd.
  • 17.21. IMV Technologies
  • 17.22. IVF Express
  • 17.23. IVFsynergy Ltd
  • 17.24. Kitazato Corporation
  • 17.25. Labotect GmbH
  • 17.26. Memmert GmbH + Co. KG
  • 17.27. Merck KGaA
  • 17.28. Nidacon International AB
  • 17.29. Nikon Corporation
  • 17.30. Nipro Corporation
  • 17.31. Olympus Corporation
  • 17.32. Overture Life, Inc.
  • 17.33. Rocket Medical plc
  • 17.34. Sysmex Corporation
  • 17.35. Terumo Corporation
  • 17.36. Thermo Fisher Scientific Inc.
  • 17.37. TMRW Life Sciences, Inc.
  • 17.38. Trajan Scientific Australia Pty Ltd.
  • 17.39. Vitrolife Group

LIST OF FIGURES

  • FIGURE 1. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IVF DEVICES & CONSUMABLES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IVF DEVICES & CONSUMABLES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CULTURE MEDIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CULTURE MEDIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DISPOSABLES & PLASTICWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DISPOSABLES & PLASTICWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DISPOSABLES & PLASTICWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM SELECTION MEDIA & DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM SELECTION MEDIA & DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM SELECTION MEDIA & DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IMAGING & MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IMAGING & MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IMAGING & MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INCUBATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY INCUBATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY LASER SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY LASER SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MICROMANIPULATOR SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OVUM ASPIRATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OVUM ASPIRATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OVUM ASPIRATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM ANALYSIS & PREPARATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM ANALYSIS & PREPARATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM ANALYSIS & PREPARATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY WORKSTATIONS & HOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY WORKSTATIONS & HOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY WORKSTATIONS & HOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ASSISTED HATCHING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ASSISTED HATCHING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ASSISTED HATCHING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONVENTIONAL IVF, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONVENTIONAL IVF, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONVENTIONAL IVF, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY EMBRYO CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY OOCYTE CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SPERM CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FERTILITY PRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FERTILITY PRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FERTILITY PRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ICSI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ICSI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY ICSI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IUI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IUI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IUI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-A, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-A, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-A, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-M, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-M, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-M, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-SR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-SR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT-SR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONTRACT RESEARCH & OUTSOURCED IVF LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONTRACT RESEARCH & OUTSOURCED IVF LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONTRACT RESEARCH & OUTSOURCED IVF LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOBANKS & SPERM BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOBANKS & SPERM BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOBANKS & SPERM BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC & GENETIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC & GENETIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY DIAGNOSTIC & GENETIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IVF CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IVF CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY IVF CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY RESEARCH CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 131. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 132. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 133. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 134. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 135. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 136. AMERICAS IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 152. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 210. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 213. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 214. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 215. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 216. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 217. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 218. GCC IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 240. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 243. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 244. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 245. G7 IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 246. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 247. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 249. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 250. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 252. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 253. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 254. NATO IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL IVF DEVICES & CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY TECHNIQUE, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY CRYOPRESERVATION, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY PGT, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 273. CHINA IVF DEVICES & CONSUMABLES MARKET SIZE, BY END USERS, 2018-2032 (USD MILLION)